Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Korea United Pharm's quarterly construction in progress
increased
from Dec. 2025 (₩22,758 Mil) to Mar. 2026 (₩27,710 Mil) but then
declined
from Mar. 2026 (₩27,710 Mil) to Jun. 2026 (₩11,062 Mil).
Korea United Pharm's annual construction in progress
declined
from Dec. 2023 (₩31,756 Mil) to Dec. 2024 (₩20,807 Mil) but then
increased
from Dec. 2024 (₩20,807 Mil) to Dec. 2025 (₩22,758 Mil).
Korea United Pharm Construction In Progress Historical Data
* Premium members only.
The historical data trend for Korea United Pharm's Construction In Progress can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korea United Pharm Construction In Progress Calculation
It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.
What does a Construction In Progress of ₩11,062 Mil mean?
Korea United Pharm (XKRX:033270) has a Construction In Progress of ₩11,062 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Korea United Pharm and its competitors.
Is Korea United Pharm's Construction In Progress too high?
Korea United Pharm's current Construction In Progress is ₩11,062 Mil. Overall, Korea United Pharm has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's Construction In Progress compare to ZTS?
Korea United Pharm's Construction In Progress of ₩11,062 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Korea United Pharm and its competitors. Korea United Pharm's current Construction In Progress is ₩11,062 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,354.74, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current Construction In Progress is ₩11,062 Mil. Korea United Pharm's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current Construction In Progress is ₩11,062 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Korea United Pharm (XKRX:033270) Overvalued in 2026?
Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued.
The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,354.74.
GuruFocus considers Korea United Pharm to be Modestly Undervalued.
Key valuation signals for XKRX:033270:
Construction In Progress: ₩11,062 Mil
GF Value™: ₩20,354.74 vs. price of ₩17,910.00 (12% below fair value)
No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
90GF Score
Get the complete analysis for XKRX:033270
Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:033270 has been successfully added to your 
